Office versus operating-room hysteroscopy for growths and tissue inside the uterus
Compares costs and quality of life for two hysteroscopy approaches in women with uterine lesions.
Key facts
- Who runs it
- Nantes University Hospital
- Where
- France9 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Office Hysteroscopy Versus Operating-room Hysteroscopy for Uterine Lesions
- Status
- Not yet recruiting
- People taking part
- 474 people, planned
- Started
- Nov 2026
- Expected to end
- Mar 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Operating-room hysteroscopy with resectoscope
- Outpatient hysteroscopic morcellation/aspiration
- Record updated
- 2 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women who need a hysteroscopy procedure to remove growths inside the womb. These are polyps, small fibroids or tissue left after a pregnancy. It compares an office procedure with one done in the operating room.
- Age
- 18 years or older
- Sex
- Female
- Disease stage
- One or more polyps, or retained pregnancy tissue, inside the womb. Or one or more submucosal fibroids, FIGO types 0, 1 or 2, of 2 cm (0.8 in) or less. A diagnostic hysteroscopy (camera look inside the womb) must confirm it.
Main reasons for not taking part
- Not wanting surgical treatment
- Blood-thinning treatment that rules out an office hysteroscopy
- Being pregnant or breastfeeding
- Active infection of the pelvis or genitals
- Being under legal protection or judicial safeguard, or unable to fill in the study questionnaires
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Female participants aged 18 years or older
- One or more intrauterine submucosal fibroids, FIGO types 0, 1 or 2, measuring 2 cm or less, confirmed by diagnostic hysteroscopy; OR one or more intrauterine polyps confirmed by diagnostic hysteroscopy; OR retained pregnancy tissue confirmed by diagnostic hysteroscopy
- Willingness to participate and provision of written informed consent
- Willingness to complete follow-up for at least 12 months after the intervention and, when the intervention is delayed after inclusion, for up to 16 months from inclusion
- Affiliation with or entitlement to a health insurance scheme
Who cannot take part
- Does not wish to undergo surgical treatment
- Active pelvic or genital infection
- Anticoagulant treatment that prevents outpatient operative hysteroscopy
- Pregnancy or breastfeeding
- Adult under a legal protection measure
- Inability to complete the study questionnaires
- Placement under judicial safeguard
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
HYPHOP is a multicenter, randomized clinical trial comparing two care pathways for women who need operative hysteroscopy to treat intrauterine lesions, such as uterine polyps, small submucosal fibroids, or retained pregnancy tissue.
Read full original descriptionShow less
Participants will be randomly assigned to one of two groups. The first group will undergo hysteroscopic morcellation/aspiration in an outpatient consultation room, without requiring an operating room. The second group will undergo hysteroscopy using a resectoscope in the operating room, usually under general or regional anesthesia.
The main objective is to determine whether outpatient hysteroscopic morcellation/aspiration provides better value for money than conventional operating-room hysteroscopy, by comparing costs and health-related quality of life over six months from inclusion.
The study will also compare symptoms, quality of life, pain, complications, the need for further treatment, patient and practitioner satisfaction, and healthcare resource use. The hypothesis is that the outpatient care pathway may reduce costs without compromising patient outcomes.
The 2 groups in the trial
- Operating-room hysteroscopy with resectoscopeExisting treatment, for comparison
Participants undergo operative hysteroscopy using a resectoscope in the operating room, with general or regional anesthesia according to the usual care pathway and clinical decision.
- Outpatient hysteroscopic morcellation/aspirationTreatment being tested
Participants undergo operative hysteroscopy using a morcellation/aspiration system in a dedicated outpatient consultation room, without an operating-room pathway. Analgesia options may include non-steroidal anti-inflammatory medication, local anesthesia, virtual reality and/or an equimolar mixture of oxygen and nitrous oxide, according to participant preference and clinical circumstances.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Cost-utility Analysis of Office Hysteroscopic Morcellation/Aspiration Versus Conventional Operating-room Resectoscopy for Intrauterine Pathologies
- Plain-language title
- Office versus operating-room hysteroscopy for growths and tissue inside the uterusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 2 November 2026